Duran Group has entered an agreement to acquire Kimble Chase Life Sciences & Research Products from Gerresheimer for a purchase consideration of $131m.

The acquisition is expected to be completed by November and will enable the acquirer to expand its presence in life sciences and research field, as well as services in the US.

Catalent subsidiary Catalent Pharma Solutions plans to expand its drug development services and spray-drying technology through the acquisition of Pharmatek laboratories.

The acquirer is an advanced drug delivery technologies and development solutions provider, whereas the target is a drug development and clinical manufacturing company.


How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.